| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 76, 1599-1603, Copyright © 1993 by Endocrine Society
ARTICLES |
L Ibanez, N Potau, R Virdis, M Zampolli, C Terzi, M Gussinye, A Carrascosa and E Vicens-Calvet
Endocrinology Unit, Hospital Materno-Infantil Vall d'Hebron, Autonomous University, Barcelona, Spain.
The postpubertal outcome of a group of girls diagnosed of premature pubarche during childhood was assessed 1) to determine the incidence of functional ovarian hyperandrogenism (FOH) through the ovarian- steroidogenic response to the GnRH agonist leuprolide acetate, 2) to validate leuprolide acetate stimulation in FOH diagnosis, and 3) to ascertain whether FOH-predictive biochemical markers exist at the diagnosis of premature pubarche. Of 35 patients (age, 15.4 +/- 1.5 yr), 16 showed hirsutism, oligomenorrhea, and elevated baseline testosterone and/or androstenedione (delta 4-A) levels. Subcutaneous administration of leuprolide acetate (500 micrograms) produced similar increases in gonadotropin levels in oligomenorrheic patients, regularly menstruating patients (n = 19), and controls (n = 12; age, 15.3 +/- 1.3 yr) when tested at 6 h. Of all of the steroids measured, 17-hydroxyprogesterone (17-OHP) and delta 4-A levels 24 h postleuprolide acetate stimulation were significantly higher in oligomenorrheic patients than in the other two groups (P < 0.0001). No overlapping in 17-OHP responses occurred between oligomenorrheic patients and the other groups. Baseline dehydroepiandrosterone sulfate and delta 4-A levels at the diagnosis of premature pubarche correlated with 17-OHP values postleuprolide acetate challenge (r = 0.47; P < 0.005 and r = 0.67; P < 0.0001, respectively). These results show a distinct leuprolide acetate challenge response in 45% of the postpubertal premature pubarche girls studied, suggestive of an increased incidence of FOH, and support the need for continued routine postmenarcheal evaluation of this group of patients. Responses of 17-OHP to leuprolide acetate challenge facilitate the identification of FOH patients, establish this test as a reliable diagnostic tool in FOH diagnosis, and confirm the ovaries as the source of hyperandrogenemia in most patients with androgen excess. Although increased 17-OHP responses after leuprolide acetate stimulation seem to occur more frequently in girls with elevated dehydroepiandrosterone sulfate and/or delta 4-A levels at the diagnosis of premature pubarche, specific biochemical markers predictive of FOH in this group of patients are still lacking.
This article has been cited by other articles:
![]() |
M. Maliqueo, T. Sir-Petermann, V. Perez, B. Echiburu, A. Ladron de Guevara, C. Galvez, N. Crisosto, and R. Azziz Adrenal Function during Childhood and Puberty in Daughters of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., September 1, 2009; 94(9): 3282 - 3288. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lappalainen, P. Utriainen, T. Kuulasmaa, R. Voutilainen, and J. Jaaskelainen Androgen Receptor Gene CAG Repeat Polymorphism and X-Chromosome Inactivation in Children with Premature Adrenarche J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1304 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibanez, A. Lopez-Bermejo, J. Callejo, A. Torres, S. Cabre, D. Dunger, and F. de Zegher Polycystic Ovaries in Nonobese Adolescents and Young Women with Ovarian Androgen Excess: Relation to Prenatal Growth J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 196 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K Ong, F. de Zegher, A. Lopez-Bermejo, D. B Dunger, and L. Ibanez Flutamide metformin for post-menarcheal girls with preclinical ovarian androgen excess: evidence for differential response by androgen receptor genotype Eur. J. Endocrinol., November 1, 2007; 157(5): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Crisosto, E. Codner, M. Maliqueo, B. Echiburu, F. Sanchez, F. Cassorla, and T. Sir-Petermann Anti-Mullerian Hormone Levels in Peripubertal Daughters of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2739 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Rosenfield Identifying Children at Risk for Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 787 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibanez, A. Jaramillo, G. Enriquez, E. Miro, A. Lopez-Bermejo, D. Dunger, and F. de Zegher Polycystic ovaries after precocious pubarche: relation to prenatal growth Hum. Reprod., February 1, 2007; 22(2): 395 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibanez, K. Ong, C. Valls, M. V. Marcos, D. B. Dunger, and F. de Zegher Metformin Treatment to Prevent Early Puberty in Girls with Precocious Pubarche J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2888 - 2891. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Nebesio and E. A. Eugster Pubic Hair of Infancy: Endocrinopathy or Enigma? Pediatrics, March 1, 2006; 117(3): 951 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Zukauskaite, D Lasiene, L Lasas, B Urbonaite, and P Hindmarsh Onset of breast and pubic hair development in 1231 preadolescent Lithuanian schoolgirls Arch. Dis. Child., September 1, 2005; 90(9): 932 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Codner, D. Mook-Kanamori, R. A. Bazaes, N. Unanue, H. Sovino, F. Ugarte, A. Avila, G. Iniguez, and F. Cassorla Ovarian Function during Puberty in Girls with Type 1 Diabetes Mellitus: Response to Leuprolide J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3939 - 3945. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Petry, K. K. Ong, K. F. Michelmore, S. Artigas, D. L. Wingate, A. H. Balen, F. de Zegher, L. Ibanez, and D. B. Dunger Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women Hum. Reprod., July 1, 2005; 20(7): 1837 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
K A Neville and J L Walker Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity Arch. Dis. Child., March 1, 2005; 90(3): 258 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Petermann, A. Cartes, M. Maliqueo, D. Vantman, C. Gutierrez, H. Toloza, B. Echiburu, and S.E. Recabarren Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: a pilot study Hum. Reprod., December 1, 2004; 19(12): 2742 - 2747. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Yildiz, K. S. Woods, F. Stanczyk, A. Bartolucci, and R. Azziz Stability of Adrenocortical Steroidogenesis over Time in Healthy Women and Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5558 - 5562. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibanez, C. Valls, M. V. Marcos, K. Ong, D. B. Dunger, and F. de Zegher Insulin Sensitization for Girls with Precocious Pubarche and with Risk for Polycystic Ovary Syndrome: Effects of Prepubertal Initiation and Postpubertal Discontinuation of Metformin Treatment J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4331 - 4337. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kaplowitz Clinical Characteristics of 104 Children Referred for Evaluation of Precocious Puberty J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3644 - 3650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Sheehan Polycystic Ovarian Syndrome: Diagnosis and Management Clin. Med. Res., February 1, 2004; 2(1): 13 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Silfen, M. R. Denburg, A. M. Manibo, R. A. Lobo, R. Jaffe, M. Ferin, L. S. Levine, and S. E. Oberfield Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4682 - 4688. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibanez, K. K. Ong, N. Mongan, J. Jaaskelainen, M. V. Marcos, I. A. Hughes, F. de Zegher, and D. B. Dunger Androgen Receptor Gene CAG Repeat Polymorphism in the Development of Ovarian Hyperandrogenism J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3333 - 3338. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibanez, K. Ong, A. Ferrer, R. Amin, D. Dunger, and F. de Zegher Low-Dose Flutamide-Metformin Therapy Reverses Insulin Resistance and Reduces Fat Mass in Nonobese Adolescents with Ovarian Hyperandrogenism J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2600 - 2606. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Pandey, S. H. Mellon, and W. L. Miller Protein Phosphatase 2A and Phosphoprotein SET Regulate Androgen Production by P450c17 J. Biol. Chem., January 24, 2003; 278(5): 2837 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Denburg, M. E. Silfen, A. M. Manibo, D. Chin, L. S. Levine, M. Ferin, D. J. McMahon, C. Go, and S. E. Oberfield Insulin Sensitivity and the Insulin-Like Growth Factor System in Prepubertal Boys with Premature Adrenarche J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5604 - 5609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Silfen, C. H. L. Shackleton, A. M. Manibo, L. S. Levine, D. Sekhar, D. J. McMahon, and S. E. Oberfield 5{alpha}-Reductase and 11{beta}-Hydroxysteroid Dehydrogenase Activity in Prepubertal Hispanic Girls with Premature Adrenarche J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4647 - 4651. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Battaglia, G. Regnani, F. Mancini, L. Iughetti, S. Bernasconi, A. Volpe, C. Flamigni, and S. Venturoli Isolated Premature Pubarche: Ultrasonographic and Color Doppler Analysis--A Longitudinal Study J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3148 - 3154. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibanez, C. Valls, A. Ferrer, K. Ong, D. B. Dunger, and F. de Zegher Additive Effects of Insulin-Sensitizing and Anti-Androgen Treatment in Young, Nonobese Women with Hyperinsulinism, Hyperandrogenism, Dyslipidemia, and Anovulation J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2870 - 2874. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Silfen, A. M. Manibo, M. Ferin, D. J. McMahon, L. S. Levine, and S. E. Oberfield Elevated Free IGF-I Levels in Prepubertal Hispanic Girls with Premature Adrenarche: Relationship with Hyperandrogenism and Insulin Sensitivity J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 398 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibanez, K. Ong, N. Potau, M. V. Marcos, F. de Zegher, and D. Dunger Insulin Gene Variable Number of Tandem Repeat Genotype and the Low Birth Weight, Precocious Pubarche, and Hyperinsulinism Sequence J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5788 - 5793. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vuguin, P. Saenger, and J. Dimartino-Nardi Fasting Glucose Insulin Ratio: A Useful Measure of Insulin Resistance in Girls with Premature Adrenarche J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4618 - 4621. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibanez, C. Valls, A. Ferrer, M. V. Marcos, F. Rodriguez-Hierro, and F. de Zegher Sensitization to Insulin Induces Ovulation in Nonobese Adolescents with Anovulatory Hyperandrogenism J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3595 - 3598. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Kaplowitz, E. J. Slora, R. C. Wasserman, S. E. Pedlow, and M. E. Herman-Giddens Earlier Onset of Puberty in Girls: Relation to Increased Body Mass Index and Race Pediatrics, August 1, 2001; 108(2): 347 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Silfen, A. M. Manibo, D. J. McMahon, L. S. Levine, A. R. Murphy, and S. E. Oberfield Comparison of Simple Measures of Insulin Sensitivity in Young Girls with Premature Adrenarche: The Fasting Glucose to Insulin Ratio May Be a Simple and Useful Measure J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2863 - 2868. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Herman, G. PA, C. Bourdony, E. Slora, R. Wasserman;, D. P. Merke, A. Pathomvanich, and G. P. Chrousos Early Puberty: A Cautionary Tale Pediatrics, March 1, 2001; 107(3): 609 - 610. [Full Text] |
||||
![]() |
L. Ibáñez, J. DiMartino-Nardi, N. Potau, and P. Saenger Premature Adrenarche--Normal Variant or Forerunner of Adult Disease? Endocr. Rev., December 1, 2000; 21(6): 671 - 696. [Abstract] [Full Text] |
||||
![]() |
S. E. Oberfield Metabolic Lessons from the Study of Young Adolescents with Polycystic Ovary Syndrome--Is Insulin, Indeed, the Culprit? J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3520 - 3525. [Full Text] |
||||
![]() |
L. Ibáñez, C. Valls, N. Potau, M. V. Marcos, and F. de Zegher Sensitization to Insulin in Adolescent Girls to Normalize Hirsutism, Hyperandrogenism, Oligomenorrhea, Dyslipidemia, and Hyperinsulinism after Precocious Pubarche J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3526 - 3530. [Abstract] [Full Text] |
||||
![]() |
L. Ibáñez, N. Potau, M. V. Marcos, and F. de Zegher Treatment of Hirsutism, Hyperandrogenism, Oligomenorrhea, Dyslipidemia, and Hyperinsulinism in Nonobese, Adolescent Girls: Effect of Flutamide J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3251 - 3255. [Abstract] [Full Text] |
||||
![]() |
A. Pathomvanich, D. P. Merke, and G. P. Chrousos Early Puberty: A Cautionary Tale Pediatrics, January 1, 2000; 105(1): 115 - 116. [Full Text] [PDF] |
||||
![]() |
Adrenal Hyperandrogenism in Children J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4431 - 4435. [Full Text] |
||||
![]() |
Corticotropin-Releasing Hormone: A Potent Androgen Secretagogue in Girls with Hyperandrogenism after Precocious Pubarche J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4602 - 4606. [Abstract] [Full Text] |
||||
![]() |
D. Jaquet, J. Leger, D. Chevenne, P. Czernichow, and C. Levy-Marchal Intrauterine Growth Retardation Predisposes to Insulin Resistance But Not to Hyperandrogenism in Young Women J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3945 - 3949. [Abstract] [Full Text] |
||||
![]() |
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibáñez, F. de Zegher, and N. Potau Anovulation after Precocious Pubarche: Early Markers and Time Course in Adolescence J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2691 - 2695. [Abstract] [Full Text] |
||||
![]() |
P. Vuguin, B. Linder, R. G. Rosenfeld, P. Saenger, and J. DiMartino-Nardi The Roles of Insulin Sensitivity, Insulin-Like Growth Factor I (IGF-I), and IGF-Binding Protein-1 and -3 in the Hyperandrogenism of African-American and Caribbean Hispanic Girls with Premature Adrenarche J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2037 - 2042. [Abstract] [Full Text] |
||||
![]() |
R. Azziz, V. Y. Black, E. S. Knochenhauer, G. A. Hines, and L. R. Boots Ovulation After Glucocorticoid Suppression of Adrenal Androgens in the Polycystic Ovary Syndrome Is Not Predicted by the Basal Dehydroepiandrosterone Sulfate Level J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 946 - 950. [Abstract] [Full Text] |
||||
![]() |
C. Ankarberg and E. Norjavaara Diurnal Rhythm of Testosterone Secretion before and throughout Puberty in Healthy Girls: Correlation with 17{beta}-Estradiol and Dehydroepiandrosterone Sulfate J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 975 - 984. [Abstract] [Full Text] |
||||
![]() |
L. D. Dorn, S. F. Hitt, and D. Rotenstein Biopsychological and Cognitive Differences in Children With Premature vs On-Time Adrenarche Arch Pediatr Adolesc Med, February 1, 1999; 153(2): 137 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gennarelli, J. Holte, M. Stridsberg, U. Lundqvist, M. Massobrio, T. Bäckström, and C. Berne Response of the Pituitary-Adrenal Axis to Hypoglycemic Stress in Women with the Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 76 - 81. [Abstract] [Full Text] |
||||
![]() |
L. Ibáñez, N. Potau, I. Francois, and F. de Zegher Precocious Pubarche, Hyperinsulinism, and Ovarian Hyperandrogenism in Girls: Relation to Reduced Fetal Growth J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3558 - 3562. [Abstract] [Full Text] |
||||
![]() |
S. Banerjee, S. Raghavan, E. J. Wasserman, B. L. Linder, P. Saenger, and J. DiMartino-Nardi Hormonal Findings in African-American and Caribbean Hispanic Girls With Premature Adrenarche: Implications for Polycystic Ovarian Syndrome Pediatrics, September 1, 1998; 102(3): e36 - e36. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Slyper Childhood Obesity, Adipose Tissue Distribution, and the Pediatric Practitioner Pediatrics, July 1, 1998; 102(1): 4e - 4. [Abstract] [Full Text] |
||||
![]() |
D. A. Ehrmann, D. J. Schneider, B. E. Sobel, M. K. Cavaghan, J. Imperial, R. L. Rosenfield, and K. S. Polonsky Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2108 - 2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ibanez, N. Potau, M. Zampolli, S. RiquE, P. Saenger, and A. Carrascosa Hyperinsulinemia and Decreased Insulin-Like Growth Factor-Binding Protein-1 Are Common Features in Prepubertal and Pubertal Girls with a History of Premature Pubarche J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2283 - 2288. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Ehrmann, M. K. Cavaghan, J. Imperial, J. Sturis, R. L. Rosenfield, and K. S. Polonsky Effects of Metformin on Insulin Secretion, Insulin Action, and Ovarian Steroidogenesis in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 524 - 530. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |